Want to join the conversation?
In 1Q16, revenues in $ISRG's largest segment, instrument and accessory, increased by approx. 16% to $322MM compared with 1Q15, primarily driven by nearly 17% growth in da Vinci procedure volume. Service revenue increased by approx. 9% to $125MM and systems revenue increased by about 5% to $148MM from 1Q15.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?